RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
Feb 2011 - 209 pages - $3,500
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?
Mar 2011 - 6 pages - $500
Pharmaceutical & Healthcare Annual Deals Analysis 2011
Mar 2011 - 107 pages - $3,500
Genzyme Corporation: PharmaVitae Profile
Aug 2010 - 98 pages - $5,700
H. Lundbeck A/S: PharmaVitae Report
Sep 2011 - 65 pages - $5,700
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2010
Jan 2011 - 80 pages - $1,500
UCB S.A.: PharmaVitae Profile
Apr 2011 - 90 pages - $3,800
Biogen Idec Inc.: PharmaVitae Profile
Oct 2010 - 92 pages - $5,700
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
OTC/Non-Prescription del
Therapeutic target
Central Nervous System del
Neurodegenerative disorders del
Development phase
Early Stage del

Browse By

Therapeutic target
Alzheimer's disease
Amyotrophic Lateral Sclerosis (Lou Gehri
Creutzfeldt-Jakob disease
Dementia
Multiple sclerosis
Parkinson's disease

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us